Ratings by Canaccord Genuity (Arlinda Lee)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
7/15/2021 Bicycle Therapeutics BCYC Maintain Buy
(N/A)
 
 
  Details
7/13/2021 Bicycle Therapeutics BCYC Maintain Buy
(N/A)
 
 
  Details
5/13/2021 BioNTech BNTX Maintain Buy
(N/A)
 
 
  Details
3/9/2021 Delcath Systems DCTH New Coverage Buy
(N/A)
17.65
(10.20)
-42.21% Details
12/14/2020 Olema Pharmaceuticals OLMA New Coverage Buy
(N/A)
43.28
(23.48)
-45.75% Details
8/21/2020 Turning Point Therapeutics Inc. TPTX Maintain Buy
(N/A)
 
 
  Details
7/21/2020 BioNTech BNTX Maintain Buy
(N/A)
 
 
  Details
7/13/2020 BioNTech BNTX Maintain Buy
(N/A)
 
 
  Details
7/13/2020 Zymeworks ZYME Maintain Buy
(N/A)
 
 
  Details
7/13/2020 Zymeworks ZYME Maintain Buy
(N/A)
 
 
  Details
7/2/2020 Ultragenyx Pharma RARE Maintain Buy
(N/A)
 
 
  Details
6/15/2020 CRISPR Therapeutics CRSP Maintain Buy
(N/A)
 
 
  Details
5/18/2020 Turning Point Therapeutics Inc. TPTX Maintain Buy
(N/A)
 
 
  Details
3/12/2020 Neoleukin Therapeutics NLTX New Coverage Buy
(N/A)
7.96
(6.99)
-12.19% Details
3/3/2020 Forty Seven Inc. FTSV Downgrade Hold
(Buy)
58.00
(95.51)
64.67% Details
2/24/2020 Black Diamond Therapeutics BDTX New Coverage Buy
(N/A)
37.92
(9.56)
-74.79% Details
11/22/2019 Harpoon Therapeutics HARP Maintain Buy
(N/A)
 
 
  Details
11/19/2019 CRISPR Therapeutics CRSP Maintain Buy
(N/A)
 
 
  Details
11/13/2019 Forty Seven Inc. FTSV Maintain Buy
(N/A)
 
 
  Details
11/12/2019 Nektar Therapeutics NKTR Maintain Buy
(N/A)
 
 
  Details
11/4/2019 BioNTech BNTX New Coverage Buy
(N/A)
16.52
(328.35)
1887.59% Details
10/28/2019 Y-mAbs Therapeutics YMAB Maintain Buy
(N/A)
 
 
  Details
9/30/2019 Bicycle Therapeutics BCYC Maintain Buy
(Buy)
 
 
  Details
9/16/2019 Fibrocell Science FCSC Downgrade Hold
(Buy)
2.92
(3.00)
2.74% Details
9/5/2019 Turning Point Therapeutics Inc. TPTX Maintain Buy
(N/A)
 
 
  Details
8/27/2019 Forty Seven Inc. FTSV Maintain Buy
(Buy)
 
 
  Details
8/14/2019 Deciphera DCPH Maintain Buy
(N/A)
 
 
  Details
8/2/2019 Blueprint Medicines BPMC Maintain Buy
(N/A)
 
 
  Details
7/26/2019 CRISPR Therapeutics CRSP New Coverage Buy
(N/A)
49.14
(121.02)
146.28% Details
5/21/2019 X4 Pharmaceuticals XFOR New Coverage Buy
(N/A)
18.64
(5.75)
-69.15% Details
5/3/2019 Zymeworks ZYME Maintain Buy
(N/A)
 
 
  Details
3/15/2019 Deciphera DCPH Maintain Buy
(N/A)
 
 
  Details
3/13/2019 Cara Therapeutics CARA Maintain Buy
(N/A)
 
 
  Details
3/5/2019 Harpoon Therapeutics HARP New Coverage Buy
(N/A)
16.20
(9.79)
-39.57% Details
2/12/2019 Tyme Technologies TYME Maintain Buy
(N/A)
 
 
  Details
11/5/2018 Tyme Technologies TYME Maintain Buy
(N/A)
 
 
  Details
10/16/2018 Y-mAbs Therapeutics YMAB New Coverage Buy
(N/A)
21.60
(33.09)
53.19% Details